SynDRA canonical compound SYN0001691 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|---|
| Primary target(s) | CACNA1B | CACNA1D | SCN10A | SCN1A | SCN2A | SCN3A | SCN4A | SCN5A | SCN9A |
| Mechanism of action | voltage-gated sodium channel blocker |